William D. McCombe
William D. McCombe's purchase track record
William D. McCombe has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 6/2/2025 | CTKB | $97K | +42.0% | +88.3% | +14.8% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 26, 2026
Velo3D Announces Leadership Strengthening to Scale Production. Velo3D said it is adding new leaders in technology and operations to support larger scale production. The changes aim to improve manufacturing efficiency and speed up product delivery. The announcement comes as the company continues to focus on expanding its 3D printing solutions.
Transaction History
| CTKB | ▲ Buy | Option Exercise | 13,051 | — | 8/18/2026 | View on chart |
| CTKB | ▼ Sell | Tax Withholding | 4,392 | $21K | 8/18/2026 | View on chart |
| CTKB | ▲ Buy | Option Exercise | 16,049 | — | 8/18/2026 | View on chart |
| CTKB | ▼ Sell | Tax Withholding | 5,401 | $25K | 8/18/2026 | View on chart |
| CTKB | ▲ Buy | Option Exercise | 6,320 | — | 8/18/2026 | View on chart |
| CTKB | ▼ Sell | Tax Withholding | 2,111 | $10K | 8/18/2026 | View on chart |
| CTKB | ▲ Buy | Option Exercise | 6,320 | — | 5/18/2026 | View on chart |
| CTKB | ▼ Sell | Tax Withholding | 2,268 | $8K | 5/18/2026 | View on chart |
| CTKB | ▲ Buy | Option Exercise | 8,700 | — | 5/18/2026 | View on chart |
| CTKB | ▼ Sell | Tax Withholding | 3,122 | $11K | 5/18/2026 | View on chart |
| CTKB | ▲ Buy | Option Exercise | 10,699 | — | 5/18/2026 | View on chart |
| CTKB | ▼ Sell | Tax Withholding | 3,839 | $14K | 5/18/2026 | View on chart |
| CTKB | ▲ Buy | Option Exercise | 6,320 | — | 3/10/2026 | View on chart |
| CTKB | ▼ Sell | Tax Withholding | 2,603 | $11K | 3/10/2026 | View on chart |
| CTKB | ▲ Buy | Option Exercise | 17,401 | — | 3/10/2026 | View on chart |
| CTKB | ▼ Sell | Tax Withholding | 7,145 | $30K | 3/10/2026 | View on chart |
| CTKB | ▲ Buy | Option Exercise | 6,320 | — | 11/18/2025 | View on chart |
| CTKB | ▼ Sell | Tax Withholding | 2,032 | $11K | 11/18/2025 | View on chart |
| CTKB | ▲ Buy | Option Exercise | 13,051 | — | 11/18/2025 | View on chart |
| CTKB | ▼ Sell | Tax Withholding | 4,196 | $23K | 11/18/2025 | View on chart |
| CTKB | ▲ Buy | Option Exercise | 6,320 | — | 8/18/2025 | View on chart |
| CTKB | ▼ Sell | Tax Withholding | 2,462 | $10K | 8/18/2025 | View on chart |
| CTKB | ▲ Buy | Option Exercise | 13,051 | — | 8/18/2025 | View on chart |
| CTKB | ▼ Sell | Tax Withholding | 5,084 | $21K | 8/18/2025 | View on chart |
| CTKB | ▲ Buy | Open Market | 35,000 | $97K | 6/2/2025 | View on chart |
| CTKB | ▲ Buy | Option Exercise | 25,283 | — | 5/19/2025 | View on chart |
| CTKB | ▼ Sell | Tax Withholding | 9,848 | $26K | 5/19/2025 | View on chart |
| CTKB | ▲ Buy | Option Exercise | 8,700 | — | 5/19/2025 | View on chart |
| CTKB | ▼ Sell | Tax Withholding | 3,389 | $9K | 5/19/2025 | View on chart |
| VELO | ▼ Sell | Open Market | 11,201 | $17K | 8/21/2023 | View on chart |
| VELO | ▲ Buy | Option Exercise | 9,935 | — | 8/15/2023 | View on chart |
| VELO | ▲ Buy | Option Exercise | 20,795 | — | 8/15/2023 | View on chart |
| VELO | ▲ Buy | Option Exercise | 9,935 | — | 5/15/2023 | View on chart |
| VELO | ▲ Buy | Option Exercise | 20,795 | — | 5/15/2023 | View on chart |
| VELO | ▼ Sell | Open Market | 11,198 | $21K | 5/15/2023 | View on chart |
| VELO | ▼ Sell | Open Market | 4,268 | $15K | 2/15/2023 | View on chart |
| VELO | ▲ Buy | Option Exercise | 9,935 | — | 2/15/2023 | View on chart |
| VELO | ▼ Sell | Open Market | 14,470 | $38K | 11/16/2022 | View on chart |
| VELO | ▲ Buy | Option Exercise | 39,740 | — | 11/15/2022 | View on chart |
| VELO | ▲ Buy | Option Exercise | 100,000 | $18K | 5/16/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 7, 2026
Cytek spotlights spectral flow cytometry at ESCCA and ICCS conferences
Cytek Biosciences drew attention to the growing use of its spectral flow cytometry technology in clinical research at the ESCCA and ICCS conferences. The company also confirmed it will attend upcoming investor conferences. These are routine participation and awareness events rather than material business updates, with no new financial figures or product announcements disclosed. The current price sits within the stock's 52-week range of $3.28 to $6.18, below the average analyst target of $5.56.
Cytek spotlights spectral flow cytometry at ESCCA and ICCS conferences. Cytek Biosciences drew attention to the growing use of its spectral flow cytometry technology in clinical research at the ESCCA and ICCS conferences. The company also confirmed it will attend upcoming investor conferences. These are routine participation and awareness events rather than material business updates, with no new financial figures or product announcements disclosed. The current price sits within the stock's 52-week range of $3.28 to $6.18, below the average analyst target of $5.56.